Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle R Downes

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Virchows Archiv : an International Journal of Pathology|August 7, 2023
Redefining and capturing pre-analytic deficiencies in an anatomical pathology laboratory: a quality improvement initiativeTra Truong, Preeya Roopchard, Ekaterina Olkhov-Mitsel, et al.
The American Journal of Surgical Pathology|May 11, 2026
The Value of Systematic Versus Targeted Sampling in Prostate Cancer Detection and the Identification of Adverse Pathologic Features: A Retrospective Review of Over 1400 Combined Prostate BiopsiesNgoc-Nhu Jennifer Nguyen, Vincent F Castillo, Ekaterina Olkhov-Mitsel, et al.
Pathology, Research and Practice|October 6, 2020
Can immune markers help identify fast relapse in patients with muscle invasive bladder cancer?Ekaterina Olkhov-Mitsel, Anjelica Hodgson, Stanley K Liu, et al.
Scientific Reports|January 14, 2022
Upregulation of IFNɣ-mediated chemokines dominate the immune transcriptome of muscle-invasive urothelial carcinomaEkaterina Olkhov-Mitsel, Anjelica Hodgson, Stan K Liu, et al.
Histopathology|August 18, 2016
Analysis of papillary urothelial carcinomas of the bladder with grade heterogeneity: supportive evidence for an early role of CDKN2A deletions in the FGFR3 pathwayMichelle R Downes, Berber Weening, Bas W G van Rhijn, et al.
The American Journal of Surgical Pathology|May 12, 2018
PD-L1 Immunohistochemistry Assay Concordance in Urothelial Carcinoma of the Bladder and Hypopharyngeal Squamous Cell CarcinomaAnjelica Hodgson, Elzbieta Slodkowska, Achim Jungbluth, et al.
Human Pathology|August 4, 2018
Reproducibility of PD-L1 immunohistochemistry interpretation across various types of genitourinary and head/neck carcinomas, antibody clones, and tissue typesChiyun Wang, Elan Hahn, Elzbieta Slodkowska, et al.
Radiology|July 16, 2024
Comparison of Multiparametric MRI-targeted and Systematic Biopsies for Detection of Cribriform and Intraductal Carcinoma Prostate CancerSangeet Ghai, Laurence Klotz, Gregory R Pond, et al.
Molecular Oncology|June 14, 2018
Modulating ATP binding cassette transporters in papillary renal cell carcinoma type 2 enhances its response to targeted molecular therapyRola M Saleeb, Mina Farag, Zsuzsanna Lichner, et al.
Proteomics. Clinical Applications|June 21, 2021
A proteomic investigation of isogenic radiation resistant prostate cancer cell linesNatalie Kurganovs, Hanzhi Wang, Xiaoyong Huang, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Virchows Archiv : an International Journal of Pathology|August 7, 2023
Redefining and capturing pre-analytic deficiencies in an anatomical pathology laboratory: a quality improvement initiativeTra Truong, Preeya Roopchard, Ekaterina Olkhov-Mitsel, et al.
The American Journal of Surgical Pathology|May 11, 2026
The Value of Systematic Versus Targeted Sampling in Prostate Cancer Detection and the Identification of Adverse Pathologic Features: A Retrospective Review of Over 1400 Combined Prostate BiopsiesNgoc-Nhu Jennifer Nguyen, Vincent F Castillo, Ekaterina Olkhov-Mitsel, et al.
Pathology, Research and Practice|October 6, 2020
Can immune markers help identify fast relapse in patients with muscle invasive bladder cancer?Ekaterina Olkhov-Mitsel, Anjelica Hodgson, Stanley K Liu, et al.
Scientific Reports|January 14, 2022
Upregulation of IFNɣ-mediated chemokines dominate the immune transcriptome of muscle-invasive urothelial carcinomaEkaterina Olkhov-Mitsel, Anjelica Hodgson, Stan K Liu, et al.
Histopathology|August 18, 2016
Analysis of papillary urothelial carcinomas of the bladder with grade heterogeneity: supportive evidence for an early role of CDKN2A deletions in the FGFR3 pathwayMichelle R Downes, Berber Weening, Bas W G van Rhijn, et al.
The American Journal of Surgical Pathology|May 12, 2018
PD-L1 Immunohistochemistry Assay Concordance in Urothelial Carcinoma of the Bladder and Hypopharyngeal Squamous Cell CarcinomaAnjelica Hodgson, Elzbieta Slodkowska, Achim Jungbluth, et al.
Human Pathology|August 4, 2018
Reproducibility of PD-L1 immunohistochemistry interpretation across various types of genitourinary and head/neck carcinomas, antibody clones, and tissue typesChiyun Wang, Elan Hahn, Elzbieta Slodkowska, et al.
Radiology|July 16, 2024
Comparison of Multiparametric MRI-targeted and Systematic Biopsies for Detection of Cribriform and Intraductal Carcinoma Prostate CancerSangeet Ghai, Laurence Klotz, Gregory R Pond, et al.
Molecular Oncology|June 14, 2018
Modulating ATP binding cassette transporters in papillary renal cell carcinoma type 2 enhances its response to targeted molecular therapyRola M Saleeb, Mina Farag, Zsuzsanna Lichner, et al.
Proteomics. Clinical Applications|June 21, 2021
A proteomic investigation of isogenic radiation resistant prostate cancer cell linesNatalie Kurganovs, Hanzhi Wang, Xiaoyong Huang, et al.
Pageof 8